Pembrolizumab,Vibostolimab,Gebasaxturev,MK-4830,Favezelimab
merck
['vibostolimab', 'pembro', '$mrk', 'merck']
#aacr23: $mrk (#merck) keymaker-u02 trial in neoadjuvant setting showed benefit of addition of the vibostolimab (anti-tigit) to pembrolizumab better orr vs pembro, however the ctla-4 and lag-3 combinations appear more robust (mpr) further investigation warranted 
Course5i prides itself in enabling #LifeSciences organizations with insights, #analytics and #AI to drive strategic decisions. Enabling better health outcomes.